Small caps last week: Canada Goose downgrade, smart glasses rollout, Volato AI pivot

Last week, parka maker Canada Goose was hit by expectations of a warm winter, with Wells Fargo downgrading the stock by two notches. Meanwhile, Innovative Eyewear, which produces smart glasses, competing with Meta for that market, is preparing to launch sales at a major U.S. retailer and has formed an alliance with Taiwanese tech giant HTC. In addition, energy small caps have emerged as bigger winners so far in 2026, gaining around three times as much as the broader market. These stories headline our recap of happenings in the small-cap space for the week of August 24-28.

Wells Fargo has downgraded shares of Canada Goose by two notches to “underweight.” The bank also cut its target price by around 40% to $10 per share. On Monday, the day the downgrade was released, Canada Goose shares fell more than 5% to $8.30 apiece.

Wells Fargo cited expectations that a warmer winter would weigh on sales. The weather is being impacted by El Niño, a natural phenomenon in which waters in the equatorial Pacific Ocean become warmer every few years, raising global temperatures and affecting precipitation. Forecasters expect a super El Niño this year, possibly the strongest ever recorded, Reuters reports.

In the third quarter of the previous fiscal year, ended in December, Canada Goose’s comparable sales rose just over 6% year over year. Wells Fargo expects weather unfavorable to parka sales to push comparable sales down 5% year over year in the current fiscal third quarter.

Wall Street is cautious on the stock, with five “sell” recommendations, five “hold” ratings, and just three “buy” calls. The average target price is $9.70 per share, around 19% above the current market price.

Smart glasses maker Innovative Eyewear, formerly Lucyd, announced that its Lucyd Armor model would go on sale at more than 150 stores operated by one of the largest U.S. retailers, which the company did not name. The same day, Innovative Eyewear announced an alliance with Taiwanese electronics producer HTC Corporation under which it will handle U.S. commercialization of HTC’s VIVE Eagle line of AI camera glasses. Innovative Eyewear shares soared 64.7% on Monday to $1.12 apiece.

The micro cap plans to begin selling the glasses through its flagship Lucyd.co online store in September. Unlike Meta, which uses its own AI models in its products, Innovative Eyewear allows customers to choose between ChatGPT and Claude through its app.

Innovative Eyewear’s net revenue for April-June rose 74% year over year, exceeding $1 million in a quarter for the first time. Operating expenses during the same period fell 10% to $1.9 million, while the net loss narrowed 21% to $1.67 million, or $0.26 per diluted share.

According to MarketWatch data, only one Wall Street analyst, from Maxim Group, covers the stock and has a “hold” rating. The target price is $3 per share, triple the stock’s last close.

Energy small caps have surged in 2026. Year to date, an Oninvest-compiled equal-weight index of such stocks has gained 38.4%, while the cap-weight version has risen 27.1%. For comparison, the Russell 2000 has added 21.7%, and the S&P 500 12.8%. The rally is broad based, including oilfield services and tanker shipping to LNG and uranium. Smaller firms have benefited from high oil prices, vessel and equipment shortages, and surging freight rates.

At the same time, the fundamental backdrop for the energy sector remains mixed. The International Energy Agency expects global oil demand to decline by 1.6 million barrels per day in 2026, while investment in oil is falling for a third consecutive year. The main driver for small caps has instead been the sharp change in market conditions following the closure of the Strait of Hormuz. The key question for investors is therefore how long high oil prices and freight rates will persist: reopening the strait could quickly eliminate the geopolitical premium and ease pressure on supply.

Picard Medical, a micro-cap maker of artificial hearts, reported second-quarter revenue that came in at around twice Wall Street’s forecast. The company’s shares surged around 200% over the trading sessions on Monday and Tuesday to $9.55 apiece.

Quarterly revenue rose 39% year over year to $3 million, versus the Wall Street forecast of $1.55 million. At the same time, the company reported a loss of $3.05 per share, wider than Wall Street’s forecast of $1.50 per share, Investing.com reports.

SynCardia, a Picard Medical subsidiary founded in 2001, manufactures and sells the only commercially available total artificial heart approved in the U.S. and Canada for patients awaiting a donor organ. The company, however, has faced difficulties. After its IPO in September last year, its shares plunged around 60% in October, while the company later faced the risk of delisting because it did not meet the NYSE American's shareholders’ equity requirements. Picard Medical subsequently announced a leadership transition and, in late July, a 1-for-50 reverse stock split to support compliance with the exchange’s listing rules.

According to MarketWatch data, only one Wall Street analyst, from H.C. Wainwright, covers the stock. They have a “hold” rating on Picard Medical without a target price.

Volato Group, a developer of aviation software, will pivot to AI infrastructure through a merger with Alignment Engine, a private company that owns an industrial campus in Ohio. Volato shares surged 55.8% on Wednesday to $0.24 apiece.

Volato will remain publicly traded, while Alignment Engine shareholders will receive Volato convertible preferred stock, which will subsequently be converted into common stock. Alignment Engine was valued at $500 million in the transaction, versus Volato’s market capitalization of $13 million at Wednesday’s close.

Volato announced its new plans two months after terminating its previous merger agreement with M2i Global, which develops critical-mineral supply chains, the transaction having not been completed by the agreed deadline.